Escherichia coli sequence type 131 (ST131) is a worldwide pandemic clone, causing
predominantly community-onset antimicrobial-resistant infection. Its pandemic spread was …

Acinetobacter baumannii is emerging as a pathogen that is commonly involved in nosocomial
infections. A. baumannii has exhibited the ability to develop multidrug resistance (MDR), …

Escherichia coli has become multiresistant by way of production of a variety of β-lactamases.
The prevalence of CTX-M–producing E. coli has reached 60–79% in certain parts of Asia. …

Escherichia coli strains causing urinary tract infection (UTI) are increasingly recognized as
belonging to specific clones. E. coli clone O25b:H4-ST131 has recently emerged globally as …

A total of 49 unique clinical isolates of multidrug-resistant (MDR) Acinetobacter baumannii
identified at a tertiary medical center in Pittsburgh, Pennsylvania, between August 2006 and …

The molecular epidemiology and mechanisms of resistance of carbapenem-resistant
Enterobacteriaceae (CRE) were determined in hospitals in the countries of the Gulf Cooperation …

A disk potentiation method using carbapenems as substrates and 3-aminophenyl boronic acid
as an inhibitor was evaluated for the detection of Klebsiella pneumoniae carbapenemase …

… Clonally related ESBL-producing E. coli isolates were detected among residents in the four
… the host strain has most often been the pandemic E. coli clone ST131. Our findings support …

A combination of phenotypic and genotypic methods was used to investigate 70 unique
Escherichia coli clinical isolates identified as producing extended-spectrum β-lactamases (…

The use of combination antibiotic therapy may be beneficial against rapidly emerging resistance
in Pseudomonas aeruginosa . The aim of this study was to systematically investigate in …